[PDF] Multinational Pharmaceutical Companies - eBooks Review

Multinational Pharmaceutical Companies


Multinational Pharmaceutical Companies
DOWNLOAD

Download Multinational Pharmaceutical Companies PDF/ePub or read online books in Mobi eBooks. Click Download or Read Online button to get Multinational Pharmaceutical Companies book now. This website allows unlimited access to, at the time of writing, more than 1.5 million titles, including hundreds of thousands of titles in various foreign languages. If the content not found or just blank you must refresh this page



Multinational Pharmaceutical Companies


Multinational Pharmaceutical Companies
DOWNLOAD
Author : Bert Spilker
language : en
Publisher: Lippincott Williams & Wilkins
Release Date : 1994

Multinational Pharmaceutical Companies written by Bert Spilker and has been published by Lippincott Williams & Wilkins this book supported file pdf, txt, epub, kindle and other format this book has been release on 1994 with Business & Economics categories.




Comparative Analysis And Benchmarking


Comparative Analysis And Benchmarking
DOWNLOAD
Author : Hung-hsin Chen
language : en
Publisher: Universal-Publishers
Release Date : 2003

Comparative Analysis And Benchmarking written by Hung-hsin Chen and has been published by Universal-Publishers this book supported file pdf, txt, epub, kindle and other format this book has been release on 2003 with Business & Economics categories.


This research of corporate strategy analysis implements comparative analysis and benchmarking to analyse and examine the corporate strategy of the pharmaceutical sectors of 4 international pharmaceutical companies. This research adopts the hybrid approach of combining qualitative and quantitative methods in a two stages research design. Quantitative method is applied first to deal with the comparative figures, and then qualitative method is used to find out the problem. The design of this multiple research includes three phases: data collection, analysis, and reporting. The findings of this research can be divided into 4 parts: R&D/marketing, technology alliances, strategic acquisitions and merger, and manufacturing. The drug innovative projects are recommended being developed within the company's familiar therapeutic areas in order to take its marketing advantage. Through this comparative analysis, some of this type of problems of these international pharmaceutical companies is identified. A big pharmaceutical company forming alliances with some small biotechnology companies has become a trend within pharmaceutical industry since 1980s. For pharmaceutical companies, to take advantage of R&D through biotechnology is the main purpose of alliances with small biotechnology companies. It is important to note that most pharmaceutical acquisitions belong to the type of absorption with high resource transferring and low autonomy. Due to the high profit margin and the essential importance of R&D and marketing, the operation management of manufacturing of pharmaceutical industry is relatively poor. The low asset utilisation rate pointed out this problem. Academic researches have revealed that existing theories of operation management of manufacturing, such as action research, set-up reduction, teamwork, continuous improvement, collaboration, and involvement, are applicable and beneficial to pharmaceutical industry rather than waiting for the technology breakthroughs.



The World S Pharmaceutical Industries


The World S Pharmaceutical Industries
DOWNLOAD
Author : Robert Ballance
language : en
Publisher: Edward Elgar Publishing
Release Date : 1992

The World S Pharmaceutical Industries written by Robert Ballance and has been published by Edward Elgar Publishing this book supported file pdf, txt, epub, kindle and other format this book has been release on 1992 with Business & Economics categories.


Provides a comprehensive study of pharmaceuticals - one of the most profitable and dynamic industries in the world. The text should be of interest to government officials and representatives of special interest groups concerned with health care, public policy and policy related issues.



Mergers And Acquisitions In The Global Pharmaceutical Industry


Mergers And Acquisitions In The Global Pharmaceutical Industry
DOWNLOAD
Author : Mennen
language : en
Publisher: GRIN Verlag
Release Date : 2010-12-17

Mergers And Acquisitions In The Global Pharmaceutical Industry written by Mennen and has been published by GRIN Verlag this book supported file pdf, txt, epub, kindle and other format this book has been release on 2010-12-17 with Business & Economics categories.


Project Report from the year 2006 in the subject Communications - Public Relations, Advertising, Marketing, Social Media, grade: 65 % - B, University of Sunderland, course: Global Corporate Strategy, language: English, abstract: Mergers and acquisitions are of major importance in the pharmaceutical industry. In order to evaluate the dynamics of this particular industry, this paper critically evaluates the pre- and post- merger situation of GlaxoSmithKline concerning its ready-access to markets, know-how and management capability. Furthermore, strengths and weaknesses and merger’s outcomes will be outlined. Critical push and pull factors affecting M&A activity in North America will be analysed, using Pfizer and Pharmacia as an example. In addition, general reasons for M&A failure in the pharmaceutical industry will be illustrated focussing on the M&A activity of GlaxoSmithKline. Finally, using two global pharmaceutical players (GSK and Astrazeneca), the merits and demerits of the McKinsey’s five step programme will be discussed.



Valuing Pharmaceutical Companies


Valuing Pharmaceutical Companies
DOWNLOAD
Author : Karen Beynon
language : en
Publisher: Woodhead Publishing
Release Date : 2000-06-19

Valuing Pharmaceutical Companies written by Karen Beynon and has been published by Woodhead Publishing this book supported file pdf, txt, epub, kindle and other format this book has been release on 2000-06-19 with Business & Economics categories.


The pharmaceutical sector offers some of the most exciting financial and business opportunities today. This essential and practical guide gives you all the tools you need to assess such opportunities. The second edition of the respected Pharmaceutical Equities, it has been thoroughly revised and updated to reflect the changes, especially in life sciences, since the first edition. The book is international in outlook, and explains the rules of the game not just for wise investing, but also for understanding how this uniquely complex and highly regulated business works. The authors explain: HOW to evaluate the technology and research and development, as well as the sales potential of ensuing products WHAT key issues will affect and influence companies in the next few years HOW to balance potential high returns on breakthrough products against accompanying risks The book begins with a look at the global pharmaceutical industry, from its history to the structure of present day companies. The second part explores how to analyse and value pharmaceutical and biotechnology companies. The final part deals with trading itself and looks at share price movement and the main equity markets throughout the world. Both practical and comprehensive, this handbook will be essential reading for investors, analysers and corporate planners - and is the ONLY book which will show you how to actually value pharmaceutical companies.



The Global Pharmaceutical Industry


The Global Pharmaceutical Industry
DOWNLOAD
Author : Daniel Hoffman
language : en
Publisher: Routledge
Release Date : 2020-07-06

The Global Pharmaceutical Industry written by Daniel Hoffman and has been published by Routledge this book supported file pdf, txt, epub, kindle and other format this book has been release on 2020-07-06 with Business & Economics categories.


The pharmaceutical industry, long thought of as a recession-proof investment, now faces a day of reckoning. The reasons for this impending downfall are not hard to discern. The prices the industry charges for its prescription drugs have escalated at four to five times the cost-of-living increases during the past two decades and have reached a point where 30% of Americans must choose between filling a prescription, paying for housing, and buying food. This has brought about public pressure on governments around the world to control drug prices, yet the world’s twenty largest pharma companies realized 80% of their growth as a result of exorbitant price hikes. Pharma currently enjoys its extraordinary profitability by exploiting the world’s most vulnerable populations. Yet even their ability to increase prices in the face of falling demand does not satisfy their profit demands. The breadth and depth of pharma’s marketing transgressions exceed those of any other industry and have now reached a point where authorities around the world have found it necessary to take legal action against its violations. Drastic change is needed if the pharmaceutical industry can equitably advance the health of the world’s population and regain public esteem. This book illustrates the range and extent of pharma’s violations and addresses the actions that should be implemented in order to make the drug industry a more constructive, less venal part of contemporary society. It will be of interest to researchers, academics, practitioners, and students with an interest in the pharmaceutical industry, healthcare management, regulation, and bioethics.



Pfizer And The Challenges Of The Global Pharmaceutical Industry


Pfizer And The Challenges Of The Global Pharmaceutical Industry
DOWNLOAD
Author : Axel Jörn
language : en
Publisher: Anchor Academic Publishing
Release Date : 2016-02-05

Pfizer And The Challenges Of The Global Pharmaceutical Industry written by Axel Jörn and has been published by Anchor Academic Publishing this book supported file pdf, txt, epub, kindle and other format this book has been release on 2016-02-05 with Business & Economics categories.


This Case Study defines the global pharmaceutical industry and its „boundaries“, analyses the profitability/attractiveness of the global pharmaceutical industry by using M.E.Porters’ Five-Forces-Model and answers the questions what overall industry trends can be identified and how the profitability/attractiveness of the industry will change in the future. Furthermore it explains and evaluates Pfizer’s new strategy and examines what Pfizer did in the recent years to maintain their profitability.



The Pharmaceutical Corporate Presence In Developing Countries


The Pharmaceutical Corporate Presence In Developing Countries
DOWNLOAD
Author : Lee A. Tavis
language : en
Publisher:
Release Date : 1993

The Pharmaceutical Corporate Presence In Developing Countries written by Lee A. Tavis and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 1993 with Business & Economics categories.


The book begins by analyzing the overall issue of multinational pharmaceutical corporate involvement in Third World locations. The contributors discuss the broad issue of conflict and collaboration between multinational corporations and activists, the role of pharmaceuticals in Third World health care, and the role of multinational corporations in that process.



External Collaborations In Multinational Pharmaceutical Companies


External Collaborations In Multinational Pharmaceutical Companies
DOWNLOAD
Author :
language : en
Publisher:
Release Date : 2020

External Collaborations In Multinational Pharmaceutical Companies written by and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 2020 with categories.




The Multinational Pharmaceutical Industry


The Multinational Pharmaceutical Industry
DOWNLOAD
Author : Sir Ronald Stanley Edwards
language : en
Publisher:
Release Date : 1974

The Multinational Pharmaceutical Industry written by Sir Ronald Stanley Edwards and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 1974 with Business & Economics categories.